A single dose of RSVPreF3 OA offered protection against RSV-related lower respiratory tract disease across three RSV seasons ...

In older adults, respiratory syncytial virus (RSV) is associated with an increased risk for cardiovascular outcome, especially heart failure events.

Despite strong clinical data, RSV immunization rates among pregnant women and older adults remain worryingly low, ...

Fact checked by Jennifer Klump Adults aged 50 and older who have certain medical conditions are now eligible to get ...

Older adults' immune systems naturally weaken with age, making them more susceptible to COVID-19, influenza (flu) and RSV. Here's what you need to know about these respiratory viruses and why ...

Respiratory syncytial virus (RSV) poses a significant, often overlooked, risk for serious cardiovascular complications in ...

Respiratory syncytial virus (RSV) is a well-known cause of infections in children, but it's understudied in older individuals ...

That compared to 59.5% for RSV-A and 57.5% for RSV-B at the visit before the second RSV season. This was much higher than the placebo, which included 3% who had immune responses to RSV-A and 7.7% ...

In adults aged 50 years and older, coadministration of respiratory syncytial virus vaccine mRNA-1345 plus seasonal influenza or COVID-19 vaccines was safe and noninferior to individual vaccine ...

Among older adults in Spain, hospitalisation rates from respiratory syncytial virus (RSV) infection increases progressively with age and is more likely among people with other health issues and ...

British drugmaker GSK said on Monday it had submitted an application to the U.S. Food and Drug Administration to extend the ...